World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
76
Citations
22462
World Ranking
18742
National Ranking
9336

Joshua Epstein publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Joshua Epstein sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 291 publications — 15th percentile

15% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Joshua Epstein D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Joshua Epstein sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 76 D-Index — 8th percentile

8% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 2008 - National Institutes of Health Director's Pioneer Award

Overview

Joshua Epstein is affiliated with the University of Arkansas for Medical Sciences in the United States. Their research spans primarily the field of medicine, with a particular focus on dermatology, public health, environmental and occupational health, epidemiology, general health professions, and surgery.

Their work covers several specialized topics including:

  • Multiple Myeloma Research and Treatments
  • Veterinary Pharmacology and Anesthesia
  • Vaccine Coverage and Hesitancy
  • Hidradenitis Suppurativa and Treatments
  • Innovations in Medical Education
  • Antibiotic Use and Resistance
  • Eating Disorders and Behaviors

Some of their recent publications include:

  • "Longer term follow-up of the randomized phase III trial SWOG S0777: bortezomib, lenalidomide and dexamethasone vs. lenalidomide and dexamethasone in patients (Pts) with previously untreated multiple myeloma without an intent for immediate autologous stem cell transplant (ASCT)" (2020), published in Blood Cancer Journal
  • "Novel Use of Home Pulse Oximetry Monitoring in COVID-19 Patients Discharged From the Emergency Department Identifies Need for Hospitalization" (2020), published in Academic Emergency Medicine
  • "Genomic Classification and Individualized Prognosis in Multiple Myeloma" (2024), published in Journal of Clinical Oncology
  • "The burden of Chronic Pelvic Pain (CPP): Costs and quality of life of women and men with CPP treated in outpatient referral centers" (2023), published in PLoS ONE
  • "Efficacy, perception, and utilization of pediatric teledermatology: A systematic review" (2023), published in JAAD International

Frequent co-authors in their research include:

  • Timothy C Jenkins
  • Holly M. Frost
  • Amy Keith
  • Joshua T.B. Williams
  • Leif Bergsagel

Joshua Epstein has several publications in notable journals such as:

  • Journal of Dental Education
  • Journal of the American Academy of Dermatology
  • Journal of Investigative Dermatology
  • Pediatric Dermatology
  • Journal of the Pediatric Infectious Diseases Society

In recognition of their research contributions, they received the National Institutes of Health Director's Pioneer Award in 2008.

Best Publications

  • The molecular classification of multiple myeloma

    Fenghuang Zhan;Yongsheng Huang;Yongsheng Huang;Simona Colla;Simona Colla;James P. Stewart;James P. Stewart

  • A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1

    John D. Shaughnessy;Fenghuang Zhan;Bart E. Burington;Yongsheng Huang

  • Bortezomib with lenalidomide and dexamethasone versus lenalidomide and dexamethasone alone in patients with newly diagnosed myeloma without intent for immediate autologous stem-cell transplant (SWOG S0777): a randomised, open-label, phase 3 trial

    Brian G.M. Durie;Antje Hoering;Muneer H. Abidi;S. Vincent Rajkumar

  • Total Therapy With Tandem Transplants for Newly Diagnosed Multiple Myeloma

    B. Barlogie;S. Jagannath;K.R. Desikan;S. Mattox

  • IRF4 addiction in multiple myeloma.

    Arthur L. Shaffer;N. C. Tolga Emre;Laurence Lamy;Vu N. Ngo

  • Extended survival in advanced and refractory multiple myeloma after single-agent thalidomide: identification of prognostic factors in a phase 2 study of 169 patients.

    Bart Barlogie;Raman Desikan;Raman Desikan;Paul Eddlemon;Paul Eddlemon;Trey Spencer;Trey Spencer

  • Multiple myeloma disrupts the TRANCE/ osteoprotegerin cytokine axis to trigger bone destruction and promote tumor progression

    Roger N. Pearse;Emilia M. Sordillo;Shmuel Yaccoby;Brian R. Wong

  • F18-fluorodeoxyglucose positron emission tomography in the context of other imaging techniques and prognostic factors in multiple myeloma

    Twyla B. Bartel;Jeff Haessler;Tracy L. Y. Brown;John D. Shaughnessy

  • Magnetic Resonance Imaging in Multiple Myeloma: Diagnostic and Clinical Implications

    Ronald Walker;Bart Barlogie;Jeffrey Haessler;Guido Tricot

  • Myeloma interacts with the bone marrow microenvironment to induce osteoclastogenesis and is dependent on osteoclast activity.

    Shmuel Yaccoby;Roger N. Pearse;Cherie L. Johnson;Bart Barlogie

  • Plasma cell myeloma--new biological insights and advances in therapy.

    Bart Barlogie;Joshua Epstein;Peter Selvanayagam;Raymond Alexanian

  • Results of high-dose therapy for 1000 patients with multiple myeloma: durable complete remissions and superior survival in the absence of chromosome 13 abnormalities.

    Raman Desikan;Bart Barlogie;Bart Barlogie;Jeffrey Sawyer;Jeffrey Sawyer;Dan Ayers;Dan Ayers

  • Primary Myeloma Cells Growing in SCID-hu Mice: A Model for Studying the Biology and Treatment of Myeloma and Its Manifestations

    Shmuel Yaccoby;Bart Barlogie;Joshua Epstein

  • Interleukin-6 Prevents Dexamethasone-Induced Myeloma Cell Death

    James Hardin;Stewart MacLeod;Irina Grigorieva;Ruixin Chang

  • Incorporating bortezomib into upfront treatment for multiple myeloma: early results of total therapy 3

    Bart Barlogie;Elias Anaissie;Frits Van Rhee;Jeffrey Haessler

  • Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencing

    L. Rasche;S. S. Chavan;O. W. Stephens;P. H. Patel

  • Role of NF-κB in the Rescue of Multiple Myeloma Cells From Glucocorticoid-Induced Apoptosis by Bcl-2

    Rena Feinman;Jadd Koury;Michael Thames;Bart Barlogie

  • Thalidomide arm of Total Therapy 2 improves complete remission duration and survival in myeloma patients with metaphase cytogenetic abnormalities.

    Bart Barlogie;Mauricio Pineda-Roman;Frits van Rhee;Jeff Haessler

  • Curing myeloma at last: defining criteria and providing the evidence

    Bart Barlogie;Alan Mitchell;Frits van Rhee;Joshua Epstein

  • Myeloma-derived Dickkopf-1 disrupts Wnt-regulated osteoprotegerin and RANKL production by osteoblasts: a potential mechanism underlying osteolytic bone lesions in multiple myeloma.

    Ya-Wei Qiang;Yu Chen;Owen Stephens;Nathan Brown

Frequent Co-Authors

Bart Barlogie
Bart Barlogie Mount Sinai Hospital
Frits van Rhee
Frits van Rhee University of Arkansas for Medical Sciences
Maurizio Zangari
Maurizio Zangari University of Arkansas for Medical Sciences
John D. Shaughnessy
John D. Shaughnessy University of Arkansas for Medical Sciences
Gareth J. Morgan
Gareth J. Morgan Boston University
Faith E. Davies
Faith E. Davies New York University Langone Medical Center
Elias Anaissie
Elias Anaissie University of Cincinnati
John Crowley
John Crowley Washington University in St. Louis
Saad Z. Usmani
Saad Z. Usmani Memorial Sloan Kettering Cancer Center
Guido Tricot
Guido Tricot University of Iowa

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in Medicine offers a variety of pathways beyond traditional medical school. Many students consider nursing as a starting point due to its versatility and demand. For those seeking a quicker entry, fast track lpn programs online provide an accelerated route to becoming a Licensed Practical Nurse, ideal for individuals eager to enter the healthcare workforce.

Specialization is also popular, particularly in mental health. The fastest psychiatric nurse practitioner program options online make it possible to advance in this high-demand field while balancing existing work or family commitments.

For those interested in healthcare management, pursuing a health administration degree online prepares graduates for leadership roles in hospitals, clinics, and other care organizations. Cost and flexibility are important factors, and there are several cheap mha programs available to help you gain expertise affordably.

These online options offer flexible, affordable ways to embark on a healthcare career, making them ideal for aspiring professionals from diverse backgrounds.

Best Scientists Citing Joshua Epstein

Trending Scientists

Recently Published Articles